The Valley Desk

NCT05568680 · Interventional trial

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

Overall registry status Recruiting

Phase 1

Conditions Cholangiocarcinoma Recurrent, Mesothelioma, Malignant, Ovarian Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov